The ANP32E Knockout A-549 Polyclonal Cells represent a CRISPR/Cas9-mediated polyclonal knockout cell population in which the ANP32E gene has been disrupted across a heterogeneous pool of A-549 cells. This product provides a powerful loss-of-function model for dissecting ANP32E-dependent chromatin dynamics, offering researchers a versatile tool to study the functional consequences of ANP32E ablation without the clonal bias of single-cell-derived lines. The polyclonal format preserves genetic diversity while ensuring robust target-gene disruption, making it particularly suited for population-level analyses of histone chaperone activity and epigenetic regulation.
The parental A-549 cell line is an adherent epithelial model derived from a 58-year-old Caucasian male with lung adenocarcinoma. It is widely employed in cancer research due to its well-characterized background, including wild-type KRAS expression and a stable genetic profile. A-549 cells retain key features of lung adenocarcinoma and are routinely used to investigate oncogenic signaling, drug responses, and tumor biology. This host cell context is ideal for exploring the role of chromatin regulators in a clinically relevant lung cancer setting, bridging basic epigenetic mechanisms and translational oncology.
ANP32E encodes an acidic leucine-rich nuclear phosphoprotein that functions as a dedicated histone chaperone, specifically catalyzing the removal of the histone variant H2A.Z from nucleosomes. This eviction activity facilitates the incorporation of histone H3.3 and remodels chromatin to regulate transcription. ANP32E is transcriptionally regulated by MYC and TP53, linking it to central oncogenic and tumor-suppressive networks. Its biochemical interactions with HIRA, DAXX, and components of the SWI/SNF complex position it as a nexus for histone exchange and nucleosome assembly. By mediating H2A.Z dynamics, ANP32E influences global chromatin structure and the expression of gene programs involved in cell proliferation and differentiation.
In the A-549 lung adenocarcinoma background, loss of ANP32E is anticipated to perturb H2A.Z occupancy and H3.3 deposition, leading to altered chromatin states that may impact cancer cell phenotypes such as growth, survival, and stress responses. Given the regulatory inputs from MYC and TP53, this knockout model enables dissection of how ANP32E integrates signals from these master regulators to control chromatin landscape and gene expression. It is particularly valuable for studying epigenetic vulnerabilities in KRAS-driven lung cancers, where chromatin remodeling pathways are often dysregulated.
This knockout product is applicable to a broad range of experimental workflows. Researchers can employ chromatin immunoprecipitation followed by qPCR or sequencing (ChIP-qPCR/ChIP-seq) to map changes in H2A.Z and H3.3 localization, as well as RNA-seq to define transcriptional consequences. Standard protein analyses such as Western blotting and immunofluorescence can validate ANP32E depletion. Functional assays including viability, clonogenic, and apoptosis assays enable phenotypic characterization, while drug sensitivity testing can identify synthetic lethal interactions or therapeutic opportunities. For additional details or custom inquiries, please contact Ascent Research.
